Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma.
Hepatology. 2019 Mar;69(3):943-958. doi: 10.1002/hep.30481.
Hepatology. 2019.
PMID: 30575985
Free PMC article.
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.
Le TBU, Vu TC, Ho RZW, Prawira A, Wang L, Goh BC, Huynh H.
Le TBU, et al.
Int J Mol Sci. 2020 Dec 10;21(24):9405. doi: 10.3390/ijms21249405.
Int J Mol Sci. 2020.
PMID: 33321903
Free PMC article.
Item in Clipboard
Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma.
Tai DWM, Le TBU, Prawira A, Ho RZW, Huynh H.
Tai DWM, et al.
Hepatol Int. 2021 Oct;15(5):1236-1246. doi: 10.1007/s12072-021-10212-8. Epub 2021 Jul 31.
Hepatol Int. 2021.
PMID: 34333737
Item in Clipboard
Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor.
Prawira A, Le TBU, Ho RZW, Huynh H.
Prawira A, et al.
J Cancer Res Clin Oncol. 2021 Oct;147(10):2955-2968. doi: 10.1007/s00432-021-03703-6. Epub 2021 Jun 22.
J Cancer Res Clin Oncol. 2021.
PMID: 34156519
Free PMC article.
Item in Clipboard
Cite
Cite